501 related articles for article (PubMed ID: 27569399)
21. Molecular Basis of mRNA Cap Recognition by Influenza B Polymerase PB2 Subunit.
Xie L; Wartchow C; Shia S; Uehara K; Steffek M; Warne R; Sutton J; Muiru GT; Leonard VH; Bussiere DE; Ma X
J Biol Chem; 2016 Jan; 291(1):363-70. PubMed ID: 26559973
[TBL] [Abstract][Full Text] [Related]
22. Potent and broad-spectrum cycloheptathiophene-3-carboxamide compounds that target the PA-PB1 interaction of influenza virus RNA polymerase and possess a high barrier to drug resistance.
Nannetti G; Massari S; Mercorelli B; Bertagnin C; Desantis J; Palù G; Tabarrini O; Loregian A
Antiviral Res; 2019 May; 165():55-64. PubMed ID: 30885750
[TBL] [Abstract][Full Text] [Related]
23. Influenza A virus RNA polymerase subunit PB2 is the endonuclease which cleaves host cell mRNA and functions only as the trimeric enzyme.
Shi L; Summers DF; Peng Q; Galarz JM
Virology; 1995 Apr; 208(1):38-47. PubMed ID: 11831724
[TBL] [Abstract][Full Text] [Related]
24. A molecular modelling approach to understand the effect of co-evolutionary mutations (V344M, I354L) identified in the PB2 subunit of influenza A 2009 pandemic H1N1 virus on m7GTP ligand binding.
Bhoye D; Behera AK; Cherian SS
J Gen Virol; 2016 Aug; 97(8):1785-1796. PubMed ID: 27154164
[TBL] [Abstract][Full Text] [Related]
25. The Short Form of the Zinc Finger Antiviral Protein Inhibits Influenza A Virus Protein Expression and Is Antagonized by the Virus-Encoded NS1.
Tang Q; Wang X; Gao G
J Virol; 2017 Jan; 91(2):. PubMed ID: 27807230
[TBL] [Abstract][Full Text] [Related]
26. Packaging signals in the 5'-ends of influenza virus PA, PB1, and PB2 genes as potential targets to develop nucleic-acid based antiviral molecules.
Giannecchini S; Wise HM; Digard P; Clausi V; Del Poggetto E; Vesco L; Puzelli S; Donatelli I; Azzi A
Antiviral Res; 2011 Oct; 92(1):64-72. PubMed ID: 21741410
[TBL] [Abstract][Full Text] [Related]
27. Structural analysis of specific metal chelating inhibitor binding to the endonuclease domain of influenza pH1N1 (2009) polymerase.
Kowalinski E; Zubieta C; Wolkerstorfer A; Szolar OH; Ruigrok RW; Cusack S
PLoS Pathog; 2012; 8(8):e1002831. PubMed ID: 22876177
[TBL] [Abstract][Full Text] [Related]
28. Strategies of development of antiviral agents directed against influenza virus replication.
Hsieh HP; Hsu JT
Curr Pharm Des; 2007; 13(34):3531-42. PubMed ID: 18220789
[TBL] [Abstract][Full Text] [Related]
29. Structure-based drug discovery for combating influenza virus by targeting the PA-PB1 interaction.
Watanabe K; Ishikawa T; Otaki H; Mizuta S; Hamada T; Nakagaki T; Ishibashi D; Urata S; Yasuda J; Tanaka Y; Nishida N
Sci Rep; 2017 Aug; 7(1):9500. PubMed ID: 28842649
[TBL] [Abstract][Full Text] [Related]
30. A novel function of the N-terminal domain of PA in assembly of influenza A virus RNA polymerase.
Suzuki T; Ainai A; Nagata N; Sata T; Sawa H; Hasegawa H
Biochem Biophys Res Commun; 2011 Nov; 414(4):719-26. PubMed ID: 22001919
[TBL] [Abstract][Full Text] [Related]
31. Influenza Polymerase Can Adopt an Alternative Configuration Involving a Radical Repacking of PB2 Domains.
Thierry E; Guilligay D; Kosinski J; Bock T; Gaudon S; Round A; Pflug A; Hengrung N; El Omari K; Baudin F; Hart DJ; Beck M; Cusack S
Mol Cell; 2016 Jan; 61(1):125-37. PubMed ID: 26711008
[TBL] [Abstract][Full Text] [Related]
32. Identification of a novel compound with antiviral activity against influenza A virus depending on PA subunit of viral RNA polymerase.
Yamada K; Koyama H; Hagiwara K; Ueda A; Sasaki Y; Kanesashi SN; Ueno R; Nakamura HK; Kuwata K; Shimizu K; Suzuki M; Aida Y
Microbes Infect; 2012 Aug; 14(9):740-7. PubMed ID: 22441116
[TBL] [Abstract][Full Text] [Related]
33. JNJ872 inhibits influenza A virus replication without altering cellular antiviral responses.
Fu Y; Gaelings L; Söderholm S; Belanov S; Nandania J; Nyman TA; Matikainen S; Anders S; Velagapudi V; Kainov DE
Antiviral Res; 2016 Sep; 133():23-31. PubMed ID: 27451344
[TBL] [Abstract][Full Text] [Related]
34. Identification of Influenza A Virus PB2 Residues Involved in Enhanced Polymerase Activity and Virus Growth in Mammalian Cells at Low Temperatures.
Hayashi T; Wills S; Bussey KA; Takimoto T
J Virol; 2015 Aug; 89(15):8042-9. PubMed ID: 26018156
[TBL] [Abstract][Full Text] [Related]
35. Biochemical characterization of recombinant influenza A polymerase heterotrimer complex: Endonuclease activity and evaluation of inhibitors.
Xing W; Barauskas O; Kirschberg T; Niedziela-Majka A; Clarke M; Birkus G; Weissburg P; Liu X; Schultz BE; Sakowicz R; Kwon H; Feng JY
PLoS One; 2017; 12(8):e0181969. PubMed ID: 28809961
[TBL] [Abstract][Full Text] [Related]
36. Identification of a small-molecule inhibitor of influenza virus via disrupting the subunits interaction of the viral polymerase.
Yuan S; Chu H; Zhao H; Zhang K; Singh K; Chow BK; Kao RY; Zhou J; Zheng BJ
Antiviral Res; 2016 Jan; 125():34-42. PubMed ID: 26593979
[TBL] [Abstract][Full Text] [Related]
37. Screening for Novel Small-Molecule Inhibitors Targeting the Assembly of Influenza Virus Polymerase Complex by a Bimolecular Luminescence Complementation-Based Reporter System.
Li C; Wang Z; Cao Y; Wang L; Ji J; Chen Z; Deng T; Jiang T; Cheng G; Qin FX
J Virol; 2017 Mar; 91(5):. PubMed ID: 28031371
[TBL] [Abstract][Full Text] [Related]
38. A Small-Molecule Compound Has Anti-influenza A Virus Activity by Acting as a ''PB2 Inhibitor".
Liu T; Liu M; Chen F; Chen F; Tian Y; Huang Q; Liu S; Yang J
Mol Pharm; 2018 Sep; 15(9):4110-4120. PubMed ID: 30102858
[TBL] [Abstract][Full Text] [Related]
39. The N terminus of PA polymerase of swine-origin influenza virus H1N1 determines its compatibility with PB2 and PB1 subunits through a strain-specific amino acid serine 186.
Wanitchang A; Jengarn J; Jongkaewwattana A
Virus Res; 2011 Jan; 155(1):325-33. PubMed ID: 21056603
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of influenza A virus by mixed siRNAs, targeting the PA, NP, and NS genes, delivered by hybrid microcarriers.
Brodskaia AV; Timin AS; Gorshkov AN; Muslimov AR; Bondarenko AB; Tarakanchikova YV; Zabrodskaya YA; Baranovskaya IL; Il'inskaja EV; Sakhenberg EI; Sukhorukov GB; Vasin AV
Antiviral Res; 2018 Oct; 158():147-160. PubMed ID: 30092251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
